0001569706-18-000001.txt : 20181106 0001569706-18-000001.hdr.sgml : 20181106 20181106172037 ACCESSION NUMBER: 0001569706-18-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181028 FILED AS OF DATE: 20181106 DATE AS OF CHANGE: 20181106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANHAM RANDALL J CENTRAL INDEX KEY: 0001278724 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12033 FILM NUMBER: 181163980 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NYMOX PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0001018735 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9900 CAVENDISH BLVD., SUITE 306 STREET 2: ST. LAURENT CITY: QUEBEC CANADA STATE: A8 ZIP: H4M 2V2 BUSINESS PHONE: 1-800-936-9669 MAIL ADDRESS: STREET 1: 9900 CAVENDISH BLVD., SUITE 306 STREET 2: ST. LAURENT CITY: QUEBEC CANADA STATE: A8 ZIP: H4M 2V2 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2018-10-28 0 0001018735 NYMOX PHARMACEUTICAL CORP NYMX 0001278724 LANHAM RANDALL J 1 1 0 0 General Counsel Common 2018-10-28 4 P 0 2900 1.72 A 152900 D Randall J. Lanham 2018-11-06